Monitoring Breast Cancer Care Quality at National and Local Level Using the French National Cancer Cohort

• Published in: Clinical breast cancer Vol. 22; no. 7; pp. e832 - e841
• Main Authors: Houzard, Sophie, Courtois, Emilie, Le Bihan Benjamin, Christine, Erbault, Marie, Arnould, Laurent, Barranger, Emmanuel, Coussy, Florence, Couturaud, Benoît, Cutuli, Bruno, de Cremoux, Patricia, de Reilhac, Pia, de Seze, Chantal, Foucaut, Aude-Marie, Gompel, Anne, Honoré, Stéphane, Lesur, Anne, Mathelin, Carole, Verzaux, Laurent, Bousquet, Philippe-Jean
• Format: Journal Article
• Language: English
• Published: Elsevier 01.10.2022
• Subjects: Cancer; Education; Food and Nutrition; Humanities and Social Sciences; Life Sciences; Santé publique et épidémiologie; Clinical good practices; Quality indicators; Breast cancer; Care pathways; Medico-administrative data
• ISSN: 1526-8209; 1938-0666
• DOI: 10.1016/j.clbc.2022.05.006

PURPOSEThe French National Cancer Institute has developed, in partnership with the French National Authority for Health, breast cancer-specific Care Quality, and Safety Indicators (BC QIs). With regard to the most common form of cancer, our aim is to support local and national quality initiatives, to improve BC pathways and outcomes, reduce heterogeneity of practice and regional inequities. In this study, we measure the BC QIs available in the French National medico-administrative cancer database, the French Cancer Cohort, for 2018. MATERIALS AND METHODSBC QIs are developed according to the RAND method. QIs are based on good clinical practice and care pathway recommendations. QI computation should be automatable without any additional workload for data collection. They will be published annually for all stakeholders, and especially hospitals. RESULTSFinally, ten feasible and pertinent QIs were selected. In France, BC care was found to be close to compliance with most QIs: proportion of patients undergoing biopsy prior to first treatment (94.5%), proportion of patients undergoing adjuvant radiotherapy after breast-conserving surgery for BC (94.5%), proportion of women undergoing radiotherapy within 12 weeks after surgery and without chemotherapy (86.2%), proportion of DCIS patients undergoing immediate breast reconstruction (54.3%) and proportion of women with NMIBC undergoing breast reintervention (14.4%). However, some are still far from their recommended rate. In particular, some QIs vary considerably from one region, or one patient, to another. CONCLUSIONEach result needs to be analyzed locally to find care quality leverage. This will strengthen transparency actions aimed at the public.